Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EffCaMgCit to Prevent Complications of Chronic PPI Therapy
NCT05998863Phase 3Withdrawn
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcium citrate + magnesium citrate in osteoporosis, hypomagnesemia, chronic kidney disease (CKD), sponsored by UT Southwestern Medical Center. Planned start Apr 2024; status: withdrawn.
02
Drugs
calcium citrate + magnesium citrate
03
Conditions
osteoporosishypomagnesemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05998863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05998863.